The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery

Published:2011-03-01 Issue:3 Volume:2 Page:275-287
ISSN:1947-6019
Container-title:Genes & Cancer
language:en
Short-container-title:Genes & Cancer

Author:

Neel N. F.,Martin T. D.,Stratford J. K.,Zand T. P.,Reiner D. J.,Der C. J.

Publisher

SAGE Publications

Subject

Cancer Research,Genetics

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MEK inhibitors and DA‐Raf, a dominant‐negative antagonist of the Ras–ERK pathway, prevent the migration and invasion of KRAS‐mutant cancer cells;Cytoskeleton;2024-06-14

2. Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling;International Journal of Molecular Sciences;2024-06-03

3. Structural insights into the complex of oncogenic KRas4B^G12Vand Rgl2, a RalA/B activator;Life Science Alliance;2023-10-13

4. The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers;Pharmaceutics;2023-06-08

5. Regulation of Ras p21 and RalA GTPases activity by quinine in mammary epithelial cells;Molecular and Cellular Biochemistry;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP